AC
Abraham Ceesay sold $87K of RAPP stock
Abraham Ceesay, Chief Executive Officer of Rapport Therapeutics, Inc. (RAPP), sold 2,210 shares of RAPP stock worth $87K, per an SEC Form 4 filed Sep 24, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Sep 23, 2026, 1 day before it was made public.
RAPP has moved -30.9% since the trade date, from $34.13 to $23.59 (Nov 19, 2026 close).
- Traded
- Sep 23, 2026
- Disclosed
- Sep 24, 2026
- Filing delay
- 1 day
- Price since
- -30.9%
- Role
- Chief Executive Officer
- Source
- SEC Form 4